CMPX
NASDAQ
$2.02
Compass Therapeutics Inc (CMPX)
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple human diseases. The company is headquartered in Boston, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $8.50 (+320.79%)
Market Cap
$385M
FCF 5Y CAGR
+49.19%
Free Cash Flow Yield
-13.83%
Beta (5Y)
1.55
Price Chart
Valuation
Market Cap$385M
P/S269.28
P/B2.10
Profitability
EBITDA-$75M
EPS-$0.41
Financial Health
Free Cash Flow Yield-13.83%
Growth & Risk
FCF 5Y CAGR+49.19%
Beta (5Y)1.55
Sharpe Ratio0.13